<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>17017111</identifier>
<setSpec>1405-9940</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Peña Duque, Marco Antonio</dc:author>
<dc:description xml:lang="en">Myocardial infarction without ST elevation and unstable angina, represents a diagnostic challenge. This Syndromes are caused by rupture of a vulnerable plaque which determines intraluminal thrombosis, distal embolism and coronary obstruction. Administration of IIb/IIIa inhibitors produces some benefits, mainly in those patients who are taking to catheterization. Coronary intervention based on a routine invasive strategy, has decreased major cardiac events principally at long term.</dc:description>
<dc:type>English Abstract</dc:type>
<dc:language>es</dc:language>
<dc:date>2006 Apr-Jun </dc:date>
<dc:title xml:lang="es">Sindrome isquémico coronario agudo sin elevación del segmento ST. Papel de los inhibidores IIb/IIIa y del intervencionismo coronario percutáneo.</dc:title>
<dc:title xml:lang="en">[Acute coronary ischemic syndrome without ST elevation. Role of glycoprotein IIB/IIIA inhibitors and percutaneous coronary interventions].</dc:title>
<dc:publisher>Archivos de cardiologia de Mexico</dc:publisher>
</metadata>
</record>
</pubmed-document>
